🇺🇸 FDA

Company profile · Sponsor

Sionna

Sionna Therapeutics

SION · NYSE pharma WALTHAM, MA, USA
Pipeline
5
Drugs
0
Patents
0

Quick answer

Sionna (SION) is a pharma company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker SION
Exchange NYSE
Company type pharma
Headquarters WALTHAM, MA, USA
SEC CIK 0002036042

Pipeline (5)

Search pipeline →

  1. Polyamide HD membrane

    Sionna

    End-stage Kidney Disease

    phase 3 other active

    1 trial

  2. pad-gauze with tranexamic acid (Hemostopan™)

    Sionna

    Bleeding

    phase 3 other active

    1 trial

  3. SION-719

    Sionna

    Cystic Fibrosis (CF)

    phase 2 small molecule active

    1 trial

  4. SION-451

    Sionna

    Cystic Fibrosis (CF)

    phase 1 small molecule active

    1 trial

  5. blood draw from three different vessels

    Sionna

    Accidental Hypothermia

    other active

    1 trial

Frequently asked questions

What is Sionna?

Sionna (SION) is a pharma company. headquartered in WALTHAM, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Sionna sponsor?

We track 5 ClinicalTrials.gov-linked programs for Sionna, including Polyamide HD membrane and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Sionna company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.